Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccines, Combined”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT04943848
What this trial is testing

RHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Who this might be right for
Diffuse Intrinsic Pontine GliomaDiffuse Midline Glioma, H3 K27M-Mutant
Ann & Robert H Lurie Children's Hospital of Chicago 36
Early research (Phase 1)Looking for participantsNCT07377435
What this trial is testing

DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM

Who this might be right for
Multiple MyelomaRefractory Multiple MyelomaRelapse Multiple Myeloma
David Avigan 25
Testing effectiveness (Phase 2)Study completedNCT03879512
What this trial is testing

Autologous Dendritic Cells, Metronomic Cyclophosphamide and Checkpoint Blockade in Children With Relapsed HGG

Who this might be right for
Childhood Glioblastoma
Wuerzburg University Hospital 24
Testing effectiveness (Phase 2)WithdrawnNCT02018419
What this trial is testing

Increased Frequency of AlloStim(TM) Dosing in Combination With Cryoablation in Metastatic Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Mirror Biologics, Inc.
Post-approval studies (Phase 4)Study completedNCT00503165
What this trial is testing

A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix

Who this might be right for
Vaccination
Public Health England 30
Large-scale testing (Phase 3)Study completedNCT00092430
What this trial is testing

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Who this might be right for
MeaslesMumpsRubella+1 more
Merck Sharp & Dohme LLC 1,200
Post-approval studies (Phase 4)Study completedNCT05161845
What this trial is testing

Clinical Trial of Measles, Mumps and Rubella Combined Vaccine, Live

Who this might be right for
ImmunotoxicityVaccine
Shanghai Institute Of Biological Products 1,068
Early research (Phase 1)Ended earlyNCT00006153
What this trial is testing

Effectiveness of Adding Remune to Your Current Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 45
Large-scale testing (Phase 3)Ended earlyNCT00925548
What this trial is testing

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Who this might be right for
Breast Cancer
EMD Serono 16
Testing effectiveness (Phase 2)Study completedNCT06683352
What this trial is testing

Learn About Flu and COVID-19 Vaccine Responses in Healthy People

Who this might be right for
Influenza,HumanCOVID-19
BioNTech SE 1,353
Testing effectiveness (Phase 2)WithdrawnNCT02466568
What this trial is testing

Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung

Who this might be right for
Lung CancerAdenocarcinoma of the Lung
H. Lee Moffitt Cancer Center and Research Institute
Large-scale testing (Phase 3)Study completedNCT00005758
What this trial is testing

Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 472
Testing effectiveness (Phase 2)Study completedNCT00551915
What this trial is testing

The Safety and Tolerability of V419 in Healthy Infants at 2,4, 6 and 12 to 14 Months of Age (V419-003)

Who this might be right for
Bacterial Infections; Virus Diseases
Merck Sharp & Dohme LLC 756
Testing effectiveness (Phase 2)Study completedNCT01248884
What this trial is testing

Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Who this might be right for
TetanusPoliomyelitisHepatitis B+3 more
GlaxoSmithKline 721
Testing effectiveness (Phase 2)Ended earlyNCT00677287
What this trial is testing

Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerColon CancerRectal Cancer
Tokyo University 14
Testing effectiveness (Phase 2)Study completedNCT03328026
What this trial is testing

Combination Study of SV-BR-1-GM With Retifanlimab

Who this might be right for
Breast CancerBreast NeoplasmMetastatic Breast Cancer+1 more
BriaCell Therapeutics Corporation 36
Large-scale testing (Phase 3)Study completedNCT00362336
What this trial is testing

Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV

Who this might be right for
Hepatitis BPolioDiphtheria+2 more
Sanofi Pasteur, a Sanofi Company 622
Post-approval studies (Phase 4)Study completedNCT01695798
What this trial is testing

IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.

Who this might be right for
Immunity to Polio Vaccines in Malnourished InfantsImmunity to Polio Vaccines in Non-malnourished Infants
Aga Khan University 840
Testing effectiveness (Phase 2)Active Not RecruitingNCT04580771
What this trial is testing

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

Who this might be right for
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise SpecifiedStage IB3 Cervical Cancer FIGO 2018Stage II Cervical Cancer FIGO 2018+11 more
M.D. Anderson Cancer Center 22
Testing effectiveness (Phase 2)Study completedNCT02153112
What this trial is testing

Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children

Who this might be right for
Norovirus
Takeda 840
Next Page